by rss feed | May 6, 2022 | biotechs, FDA, News Feeds, perinatal cell therapy, perinatal stem cells
If there’s one area of biologics where the FDA has been consistently busy lately it’s the perinatal cell therapy space. The agency has made it clear in the last year that allogeneic birth-related cell products are often drugs requiring premarket approval....
by rss feed | Feb 15, 2022 | biotechs, clinical trials, Mayo Clinic, News Feeds, therapeutic misconception
What if some legit place like The Mayo Clinic charged people just for the opportunity to talk to a doctor about possibly enrolling in a clinical trial? Imagine this kind of conversation. “Hey, Doc, I have this medical problem and heard you have a relevant...
by rss feed | Feb 23, 2021 | biotechs, Blog, News Feeds, regenerative medicine advanced therapy (RMAT), regenerative medicine biotechs, RMAT list, stem cell biotech, stem cell stocks
Stem cell stocks, meaning cellular therapy biotech companies, face many challenges, but their clinical research is crucial. These biotechs have ups and downs, sometimes at the same time. This is kind of the standard of “life” as any biotech company. It is...
by rss feed | Feb 16, 2021 | biotechs, Bluebird Bio, gene therapy, News Feeds, Sickle Cell Disease
Recently I was going through a list I’m updating of regenerative medicine biotech companies including Bluebird Bio. Now just a few days later the world seems turned upside down for the firm and maybe to some degree for other companies doing related work....
